Minocycline in Patients With Huntington's Disease

NCT00029874 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

63

Enrollment

FED

Sponsor class

Conditions

Huntington's Disease

Interventions

DRUG: Minocycline

Sponsor

FDA Office of Orphan Products Development